New research suggests that individuals who come off blockbuster weight-loss injections like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle plans.
Findings released in a prominent health publication demonstrates that while overweight people can lose a large proportion of their total mass while undergoing treatment, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Users buying such treatments should be cognizant of the danger of rapid weight regain when the treatment is stopped," warns expert Dr. Susan Jebb.
That rate of regain suggests a reversion to pre-treatment mass in about one and a half years.
Analyzing Approaches
The research, which reviewed dozens of studies involving thousands of patients, contrasted the results of the injectable medications with older methods.
The team point out that individuals who lose weight through dieting usually see a more gradual creep back—around 100 grams monthly—post-intervention.
Explaining the Fast Regain
Nutrition scientists suggest the mode of action of the jabs is key to understanding the amplified regain.
The injections imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing the hormone levels several times higher than the body's typical production could lead to the system to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication results in appetite is no longer kept in check, making binge eating far more likely."
A Chronic Issue?
The NHS suggest the injections for individuals with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Professionals argue that, due to the likelihood of weight regain, the treatment is often long-term.
This perspective is supported by pharmaceutical companies, who state that the results "highlight the chronic character of obesity," akin to managing diseases like diabetes.
User Testimonies
Individuals who have come off the jabs describe a sudden resurgence of cravings.
"It was like something that goes on and you're instantly ravenous," said a patient.
The struggle is compounded if users have not developed lasting dietary or behavioural changes during treatment.
Significant Interest
Survey data suggest that a significant number of adults in the UK have used weight-loss jabs in the past year, with interest remaining high.
- Use is more common among women compared to men.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the drugs through private healthcare rather than public health services.
Ultimately, clinicians stress that while these medications are potent agents for weight loss, they are not a standalone solution and long-term success relies on integrated behavioural changes.
